Filter by: Subject

Filter by: Subject

Results Per Page:

Human immunodeficiency virus (HIV) (8)
South Africa (SA) (7)
Sexually transmitted infection (STI) (5)
Tuberculosis (TB) (5)
Polymerase chain reaction (PCR) (4)
Bedaquiline (3)
Extensively drug-resistant tuberculosis (XDR-TB) (3)
Multidrug-resistant tuberculosis (MDR-TB) (3)
Mutation (3)
Patients (3)
Pregnancy (3)
Clofazimine (2)
Drug resistance (2)
Genome (2)
Linezolid (2)
Men who have sex with men (MSM) (2)
Multi-drug resistant tuberculosis (MDR-TB) (2)
Multidrug-resistant (MDR) (2)
Mycobacterium tuberculosis (MTB) (2)
Pulsed field gel electrophoresis (PFGE) (2)
Rifampicin-resistant tuberculosis (2)
Risk factors (2)
Trichomonas vaginalis (2)
Whole-genome sequencing (WGS) (2)
Women (2)
Acinetobacter baumannii (1)
Adaptation (1)
Adult gonorrhea (1)
Africa (1)
Amides (1)
Amino acid (AA) (1)
Angiogenic factors (1)
Anti-tuberculosis drugs (1)
Antibiotic resistance (1)
Antibiotics (1)
Antimicrobial (1)
Antimicrobial susceptibility testing (1)
Antiretroviral therapy (ART) (1)
Area under the curve (1)
Autophagy research (1)
Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence (1)
Bacteremia (1)
Bacteria (microorganisms) (1)
Bacterial DNA load (BDL) (1)
Bacterial infections (1)
Bacterial resistance (1)
Bedaquiline (BDQ) (1)
Biolog (1)
Biological marker (1)
Birth outcomes (1)
Birth weight (1)
blaOXA-23-like (1)
Bloodstream infections (1)
Bovine mastitis (1)
Capreomycin (1)
Carbapenemases (1)
Catheter-related bloodstream infections (CRBSI) (1)
CD4+ T lymphocyte (1)
Cefotaxime (1)
Children (1)
China (1)
Chlamydia trachomatis (1)
Ciprofloxacin (1)
Clofazimine (CFZ) (1)
Coagulase-negative staphylococci (CoNS) (1)
Complex (1)
Condom use (1)
Conjugative elements (1)
Culture (1)
Culture conversion (1)
Cut-off value (ECV) (1)
Cystic fibrosis (CF) (1)
Data audits (1)
Data quality (1)
Data use practices (1)
Decidual NK cells (1)
Disease severity (1)
Draft genome sequence (1)
Drug resistant tuberculosis (DR-TB) (1)
Drug sensitivity (1)